The MarketWatch News Department was not involved in the creation of this content. New capabilities introduce industry-leading AI accuracy, automate testing, and bring agentic control testing to ...

In persons with type 1 diabetes and high glycated hemoglobin levels, the benefits of intermittently scanned continuous glucose monitoring with optional alarms for high and low blood glucose levels are ...

New capabilities introduce industry-leading AI accuracy, automate testing, and bring agentic control testing to ArcherIRM users. PALO ALTO, Calif., March 23, 2026 /PRNewswire/ -- Trustero AI, the ...

TrustCloud's new application in the ServiceNow Store syncs validated control signals natively with ServiceNow IRM, SecOps, and CMDB, turning the ServiceNow Platform into an integrated security and ...

Safe AI at scale requires centralised control, monitoringBy Tracy Burrows for Veeam Software South AfricaJohannesburg, 22 May 2026 Mark Govender, manager: Technical Sales, Africa, Veeam. (Image: ...

Claims data reveal larger hemoglobin A1c decreases in people with type 2 diabetes who use continuous glucose monitoring and semaglutide compared with semaglutide alone. Study Design: Using US health ...